Hey worthind, I like your thinking on the Tibotec deal.... I pulled this from the independent report released early in Feb of this year (the same report that valued Avexa's pipeline other than ATC at $0 to $3mill), which by the reports admission was undervaluing the worth of Avexa's pipeline.
"Payments under licensing deals involving HIV drug programs
Oct 2006 Merck & Co Ambrilia Pre-Clinical $US229.0m
Sep 2006 Bristol-Myers Medivir Pre-Clinical $US104.5m
Both these are upfront and milestone payments only. Excluding royalties "
If Avexa can get something close to this for their Integrase deal it will be happy days for all.
Joe
- Forums
- ASX - By Stock
- AVX
- nother nice start to the morning
nother nice start to the morning, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
AVH
Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
STX
Strike hands $48.5M contract to Clarke Energy to produce 20x 4.5MW gas engines for Sth Erregulla